Showjumpers, eventers and racehorses are discovering the benefits of the latest innovative problem-solving product from world equine nutrition experts, Cavalor.

Their latest product, Bronchix Pulmo, is an easily administered paste supplement that offers pulmonary support to horses experiencing respiratory issues and reduced performance.  The herbal mixture works by strengthening blood vessels, improves tissue elasticity and helps to maintain airway patency in the equine respiratory system. The research shows this helps resolve EIPH disease and can be used as a preventative measure to avoid the occurrence of EIPH.

Horses have been diagnosed with EIPH from all disciplines, especially those that include intense or fast bouts of exercise. A recent study that involved over 900 horses revealed that the incidence of EIPH in show-jumpers that participated at the 4 and 5 star level can be up to 50%.

A recent clinical study (view results: https://www.cavalor.com/us-en/info/news-article/1455/clinical-study-cavalor-bronchix-pulmo) conducted by Dr. Emmanuelle van Erck-Westergren and Dr. Fe ter Woort of Equine Sports Medicine Practice, Waterloo, Belgium, demonstrated that daily use of Cavalor Bronchix Pulmo oral supplementation during a 25 day period significantly reduced the incidence and severity of EIPH in Thoroughbred racehorses during a period of intensive training. This study is the first phase of Cavalor’s research proving the product’s efficacy. The results showed that none of the horses studied bled at T2 (a key measurement for EIPH). Their results showed that Cavalor Bronchix Pulmo had a mild anti-inflammatory effect and reduced signs of inflammation in the lower airways. The red blood cells in the samples were drastically reduced, and the conclusion was that none of the horses had experienced lung bleeding after the treatment